Name | 5-Bromo-quinoline |
Synonyms | 5-Bromoquinoline 5-BROMOQUINOLINE 5-bronoquinoline 5-Bromo-quinoline 5-bromooquinoline RARECHEM AK ML 0010 Quinoline, 5-bromo- |
CAS | 4964-71-0 |
EINECS | 639-373-5 |
InChI | InChI=1/C9H6BrN/c10-8-4-1-5-9-7(8)3-2-6-11-9/h1-6H |
InChIKey | CHODTZCXWXCALP-UHFFFAOYSA-N |
Molecular Formula | C9H6BrN |
Molar Mass | 208.05 |
Density | 1.5617 (rough estimate) |
Melting Point | 43-48 °C |
Boling Point | 105-107°C 1mm |
Flash Point | 105-107°C/1mm |
Vapor Presure | 0.00261mmHg at 25°C |
Appearance | Light green powder |
Color | White to Light yellow to Green |
BRN | 115148 |
pKa | 3.88±0.12(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.6641 (estimate) |
MDL | MFCD00234481 |
Physical and Chemical Properties | Light yellow liquid |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R22 - Harmful if swallowed |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
HS Code | 29334900 |
Hazard Note | Irritant |
use | 5-bromoquinoline is a structural fragment with important physiologically active substances, and is widely used in the synthesis of pharmaceutical intermediates, such as the synthesis of anticancer drug enhancers, receptor tyrosine kinase inhibitors and cardiotonic agents. |
preparation | use p-bromoaniline and glycerol in sulfuric acid system, add nitrobenzene and ferrous sulfate to carry out reflux reaction. after the reaction, adjust the PH to 5~6 with 50% sodium hydroxide, filter out iron salt and other solid waste, extract with ethyl acetate, dry with anhydrous sodium sulfate, concentrate and distill to obtain a light yellow viscous liquid with a content ≥ 98%(HPLC area consolidation method). |